Programmed cell deathreceptor-1/programmed death ligand-1 (PD-1-/PD-L1)-basedcancer immunotherapy is a popular and promising approach for manytypes of cancer treatment, especially in TNBC. The gene discussed is CD274; the disease is cancer.